166 related articles for article (PubMed ID: 27368035)
1. Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.
Keng LT; Lin MW; Huang HN; Chung KP
Medicine (Baltimore); 2016 Jun; 95(26):e4044. PubMed ID: 27368035
[TBL] [Abstract][Full Text] [Related]
2. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T; Inokuma S; Sato T; Otsuka T; Saeki Y; Takeuchi T; Matsuda T; Takemura T; Sagawa A;
Rheumatology (Oxford); 2009 Sep; 48(9):1069-72. PubMed ID: 19321513
[TBL] [Abstract][Full Text] [Related]
3. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
Ochi S; Harigai M; Mizoguchi F; Iwai H; Hagiyama H; Oka T; Miyasaka N
Mod Rheumatol; 2006; 16(5):316-20. PubMed ID: 17039315
[TBL] [Abstract][Full Text] [Related]
4. [Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide].
Siemion-Szcześniak I; Bartoszuk I; Bartosiewicz M; Jakubowska L; Wesołowski S; Kuś J
Pneumonol Alergol Pol; 2014; 82(6):568-75. PubMed ID: 25339568
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Roubille C; Haraoui B
Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
[TBL] [Abstract][Full Text] [Related]
6. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
[TBL] [Abstract][Full Text] [Related]
7. Clinical expression of leflunomide-induced pneumonitis.
Chikura B; Lane S; Dawson JK
Rheumatology (Oxford); 2009 Sep; 48(9):1065-8. PubMed ID: 19321511
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy.
Rozin A; Yigla M; Guralnik L; Keidar Z; Vlodavsky E; Rozenbaum M; Nahir AM; Balbir-Gurman A
Clin Rheumatol; 2006 May; 25(3):384-8. PubMed ID: 16211338
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
Suissa S; Hudson M; Ernst P
Arthritis Rheum; 2006 May; 54(5):1435-9. PubMed ID: 16645972
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury.
Inokuma S
Expert Opin Drug Saf; 2011 Jul; 10(4):603-11. PubMed ID: 21410426
[TBL] [Abstract][Full Text] [Related]
11. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
12. Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature.
Kim SH; Yoo WH
Rheumatol Int; 2011 Jul; 31(7):919-22. PubMed ID: 19862529
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung diseases after leflunomide use in nephropathy: an analysis of reported cases in Chinese literature.
Zhang WX; Zhou W; Zhang ZQ; Zhao XW
Nephrol Dial Transplant; 2011 Apr; 26(4):1416-20. PubMed ID: 21193642
[TBL] [Abstract][Full Text] [Related]
14. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
[No Abstract] [Full Text] [Related]
15. Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
Sato T; Inokuma S; Sagawa A; Matsuda T; Takemura T; Otsuka T; Saeki Y; Takeuchi T; Sawada T;
Rheumatology (Oxford); 2009 Oct; 48(10):1265-8. PubMed ID: 19651883
[TBL] [Abstract][Full Text] [Related]
16. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
17. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Flendrie M; Creemers MC; Welsing PM; van Riel PL
Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis.
Maskey-Warzęchowska M; Karwat K; Szczepankiewicz B; Langfort R; Szołkowska M; Chazan R
Pneumonol Alergol Pol; 2015; 83(1):50-4. PubMed ID: 25577534
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease.
Kim JW; Chung SW; Pyo JY; Chang SH; Kim MU; Park CH; Lee JS; Lee JS; Ha YJ; Kang EH; Lee YA; Park YB; Lee EY; Choe JY
Rheumatology (Oxford); 2023 Jul; 62(7):2377-2385. PubMed ID: 36394143
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide-induced pulmonary hypertension in a young woman with rheumatoid arthritis: a case report.
Alvarez PA; Saad AK; Flagel S; Mazzocchi O; Blanco MV
Cardiovasc Toxicol; 2012 Jun; 12(2):180-3. PubMed ID: 22270725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
